Utility and limitations of long-term monitoring of atrial fibrillation using an implantable loop recorder

Heart Rhythm

Volumn 15, Issue 2, 2018, Pages 287-295

  Lee, Randall ^a   Mittal, Suneet ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b The Valley Health System   (United States)

Author keywords

Atrial fibrillation; ECG monitoring; Implantable loop recorder; Limitations; Technology; Utility

Indexed keywords

ALGORITHM; ANTICOAGULATION; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CEREBROVASCULAR ACCIDENT; CLINICAL DECISION MAKING; CLINICAL TRIAL (TOPIC); DISEASE BURDEN; ELECTROCARDIOGRAPHY MONITORING; HIGH RISK PATIENT; HUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; R WAVE AMPLITUDE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TECHNOLOGY; AMBULATORY ELECTROCARDIOGRAPHY; DEVICES; ELECTRODE IMPLANT; EQUIPMENT DESIGN; PATHOPHYSIOLOGY; TIME FACTOR; UTILIZATION;

ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY, AMBULATORY; ELECTRODES, IMPLANTED; EQUIPMENT DESIGN; HUMANS; TIME FACTORS;

EID: 85031405279     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2017.09.009     Document Type: Article

References (35)

1. Wolf, P.A., Benjamin, E.J., Belanger, A.J., Kannel, W.B., Levy, D., D'Agostino, R.B., Secular trends in the prevalence of atrial fibrillation: the Framingham Study. Am Heart J 131 (1996), 790–795.
2. Kannel, W.B., Wolf, P.A., Benjamin, E.J., Levy, D., Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82 (1998), 2N–9N.
3. Wang, T.J., Larson, M.G., Levy, D., Benjamin, E.J., Corey, D., Leip, E.P., Vasan, R.S., Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107 (2003), 2920–2925.
4. Krahn, A.D., Manfreda, J., Tate, R.B., Mathewson, F.A., Cuddy, T.E., The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98 (1995), 476–484.
5. Stewart, S., Hart, C.L., Hole, D.J., McMurray, J.J., A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 113 (2002), 359–364.
6. Ott, A., Breteler, M.M., de Bruyne, M.C., van Harskamp, F., Grobbee, D.E., Hofman, A., Atrial fibrillation and dementia in a population-based study: the Rotterdam Study. Stroke 28 (1997), 316–321.
7. Kim, M.H., Johnston, S.S., Chu, B.C., Dalal, M.R., Schulman, K.L., Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes 4 (2011), 313–320.
8. Strickberger, S.A., Ip, J., Saksena, S., Curry, K., Bahnson, T.D., Ziegler, P.D., Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm 2 (2005), 125–131.
9. Mittal, S., Movsovitz, C., Steinberg, J.S., Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation. J Am Coll Cardiol 58 (2011), 1741–1749.
10. Gladstone, D.J., Spring, M., Dorian, P., et al., for the EMBRACE Investigators and Coordinators. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 270 (2014), 2467–2477.
11. Sanna, T., Diener, H.C., Passman, R.S., et al., for the CRYSTAL AF investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370 (2014), 2478–2486.
12. Mittal, S., Rogers, J., Sarkar, S., Koehler, J., Warman, E.N., Tomson, T.T., Passman, R.S., Real-world performance of an enhanced atrial fibrillation detection algorithm in an insertable cardiac monitor. Heart Rhythm 13 (2016), 1624–1630.
13. Van Gelder, I.C., Healey, J.S., Crijns, H.J.G.M., Wang, J., Hohnloser, S.H., Gold, M.R., Capucci, A., Lau, C.P., Morillo, C.A., Hobbelt, A.H., Rienstra, M., Connolly, S.J., Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J 38 (2017), 1339–1344.
14. Charitos, E.I., Purerfellner, H., Glotzer, T.V., Ziegler, P.D., Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices. J Am Coll Cardiol 63 (2014), 2840–2848.
15. Hindricks, G., Pokulashov, E., Urban, L., Taborsky, M., Kuch, K.H., Lebedev, D., Rieger, G., Purerfellner, H., on behalf of the XPECT Trial Investigators. Performance of a new implantable cardiac monitor in detecting and quantifying atrial fibrillation: results of the XPECT Trial. Circ Arrhythm Electrophysiol 3 (2010), 141–147.
16. Pokushalov, E., Romanov, A., Corbucci, G., Artyomenko, S., Turov, A., Shirokova, N., Karaskov, A., Use of an implantable monitor to detect arrhythmia recurrences and select patients for early repeat catheter ablation for atrial fibrillation: a pilot study. Circ Arrhythm Electrophysiol 4 (2011), 823–831.
17. Lacour, P., Dang, P.L., Huemer, M., Parwani, A.S., Attanasio, P., Pieske, B., Boldt, L.H., Haverkamp, W., Blaschke, F., Performance of the new BioMonitor 2-AF insertable cardiac monitoring system: can better be worse?. Pacing Clin Electrophysiol 40 (2017), 516–526.
18. Sanders, P., Pürerfellner, H., Pokushalov, E., Sarkar, S., DiBacco, M., Maus, B., Dekker, L.R., Performance of a new AF detection algorithm in a miniaturized insertable cardiac monitor: results from the Reveal LINQ usability study. Heart Rhythm 13 (2016), 1425–1430.
19. Mittal, S., Differentiating paroxysmal from persistent atrial fibrillation: long-term ECG monitoring is mightier than the clinician. J Am Coll Cardiol 63 (2014), 2849–2850.
20. Zuern, C.S., Killias, A., Berlitz, P., Seizer, P., Gramlich, M., Muller, K., Duckheim, M., Gawaz, M., Schreieck, J., Anticoagulation after catheter ablation of atrial fibrillation guided by implantable cardiac monitors. Pacing Clin Electrophysiol 38 (2015), 688–693.
21. Passman, R., Leong-Sit, P., Andrei, A.C., Huskin, A., Tomson, T.T., Bernstein, R., Ellis, E., Waks, J.W., Zimetbaum, P., Targeted anticoagulation for atrial fibrillation guided by continuous rhythm assessment with an insertable cardiac monitor: the Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) pilot study. J Cardiovasc Electrophysiol 27 (2016), 264–270.
22. Calkins, H., Hindricks, G., Cappato, R., et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 14 (2017), e275–e444.
23. Glotzer, T.V., Hellkamp, A.S., Zimmerman, J., et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke. Circulation 107 (2003), 1614–1619.
24. Healey, J.S., Connolly, S.J., Gold, M.R., et al., for the ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366 (2012), 120–129.
25. Boriani, G., Tukkie, R., Manolis, A.S., et al., for the MINERVA Investigators. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Eur Heart J 35 (2014), 2352–2362.
26. Glotzer, T.V., Daoud, E.G., Wyse, D.G., et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2 (2009), 474–480.
27. Capucci, A., Santini, M., Padeletti, L., et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 46 (2005), 1913–1920.
28. http://manuals.medtronic.com/wcm/groups/mdtcom_sg/@emanuals/@era/@crdm/documents/documents/contrib_185856.pdf. Accessed October 6, 2017.
29. Lauschke, J., Busch, M., Haverkamp, W., et al. New implantable cardiac monitor with three-lead ECG and active noise detection [published online ahead of print October 28, 2016]. Herz 42:6 (2017), 585–592.
30. Nolker, G., Mayer, J., Boldt, L.H., et al. Performance of an implantable cardiac monitor to detect atrial fibrillation: results of the DETECT AF study. J Cardiovasc Electrophysiol 27 (2016), 1403–1410.
31. Pürerfellner, H., Pokushalov, E., Sarkar, S., Koehler, J., Zhou, R., Urban, L., Hindricks, G., P-wave evidence as a method for improving algorithm to detect atrial fibrillation in insertable cardiac monitors. Heart Rhythm 11 (2014), 1575–1583.
32. Ciconte, G., Saviano, M., Gianelli, L., et al. Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: the atrial fibrillation detect study. Europace 19 (2017), 1101–1108.
33. Podd, S.J., Sugihara, C., Furniss, S.S., Sulke, N., Are implantable cardiac monitors the “gold standard” for atrial fibrillation detection? A prospective randomized trial comparing atrial fibrillation monitoring using implantable cardiac monitors and DDDRP permanent pacemakers in post fibrillation ablation patients. Europace 18 (2016), 1000–1005.
34. Pürerfellner, H., Sanders, P., Pokushalov, E., Di Bacco, M., Bergemann, T., Dekker, L.R., Miniaturized Reveal LINQ insertable cardiac monitoring system: first-in-human experience. Heart Rhythm 12 (2015), 1113–1119.
35. Passman, R.S., Rogers, J.D., Sarkar, S., et al. Development and validation of a dual sensing scheme to improve accuracy of bradycardia and pause detection in an insertable cardiac monitor. Hearty Rhythm 14 (2017), 1016–1023.